Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis (Q45037418)
Jump to navigation
Jump to search
scientific article published on 12 April 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis |
scientific article published on 12 April 2012 |
Statements
1 reference
Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis (English)
1 reference
Alexandre Prat
1 reference
Nathalie Arbour
1 reference
Jennifer L Berard
1 reference
Juan G Zarruk
1 reference
V Wee Yong
1 reference
Francois H Jacques
1 reference
Shizuo Akira
1 reference
Samuel David
1 reference
12 April 2012
1 reference
1 reference
60
1 reference
7
1 reference
1145-1159
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference